Short-term

It is about ensuring daily comfort and combatting the signs of lupus activity, especially preserving the functions of vital organs in severe flares. This is achieved by fighting inflammation (Hydroxychloroquine, nonsteroidal anti-inflammatory drugs or corticosteroids), and decreasing the activation of the immune system (Hydroxychloroquine, corticosteroids and immunosuppressants).

Medium term

It is to prevent flares (hydroxychloroquine, corticosteroids and immunosuppressants), to prevent the occurrence of new blood clots or thrombotic recurrences (aspirin, anticoagulant), and to fight the evolution of visceral damage.

Long-term

The aim is to limit the negative effects of lupus and the late side effects of treatments by preventing infections, corticosteroid-induced osteoporosis and cardiovascular risks.